These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37880481)

  • 1. Metabolomic profiling of preterm birth in pregnant women living with HIV.
    Tobin NH; Murphy A; Li F; Brummel SS; Fowler MG; Mcintyre JA; Currier JS; Chipato T; Flynn PM; Gadama LA; Saidi F; Nakabiito C; Koos BJ; Aldrovandi GM;
    Metabolomics; 2023 Oct; 19(11):91. PubMed ID: 37880481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV.
    Conroy AL; McDonald CR; Gamble JL; Olwoch P; Natureeba P; Cohan D; Kamya MR; Havlir DV; Dorsey G; Kain KC
    Am J Obstet Gynecol; 2017 Dec; 217(6):684.e1-684.e17. PubMed ID: 29031892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy in pregnancy: balancing the risk of preterm delivery with prevention of mother-to-child HIV transmission.
    Townsend CL; Tookey PA; Newell ML; Cortina-Borja M
    Antivir Ther; 2010; 15(5):775-83. PubMed ID: 20710059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
    Short CE; Douglas M; Smith JH; Taylor GP
    HIV Med; 2014 Apr; 15(4):233-8. PubMed ID: 24025074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team.
    Lambert JS; Watts DH; Mofenson L; Stiehm ER; Harris DR; Bethel J; Whitehouse J; Jimenez E; Gandia J; Scott G; O'Sullivan MJ; Kovacs A; Stek A; Shearer WT; Hammill H; van Dyke R; Maupin R; Silio M; Fowler MG
    AIDS; 2000 Jul; 14(10):1389-99. PubMed ID: 10930154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone and prolactin levels in pregnant women living with HIV who delivered preterm and low birthweight infants: A nested case-control study.
    Chi BH; Sebikari D; Brummel SS; DeMarrais P; Chamanga R; Owor M; Dadabhai S; Price JT; Taha T; Stringer J; Fowler MG
    PLoS One; 2023; 18(1):e0280730. PubMed ID: 36689442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (2):CD003510. PubMed ID: 12076484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (1):CD003510. PubMed ID: 11869666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcomes in HIV-positive women in Ukraine, 2000-12 (European Collaborative Study in EuroCoord): an observational cohort study.
    Bagkeris E; Malyuta R; Volokha A; Cortina-Borja M; Bailey H; Townsend CL; Thorne C;
    Lancet HIV; 2015 Sep; 2(9):e385-92. PubMed ID: 26423552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome among HIV-infected women on different antiretroviral therapies in Ethiopia: a cohort study.
    Ejigu Y; Magnus JH; Sundby J; Magnus MC
    BMJ Open; 2019 Aug; 9(8):e027344. PubMed ID: 31383698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.
    Rough K; Seage GR; Williams PL; Hernandez-Diaz S; Huo Y; Chadwick EG; Currier JS; Hoffman RM; Barr E; Shapiro DE; Patel K;
    N Engl J Med; 2018 Apr; 378(17):1593-1603. PubMed ID: 29694825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
    Venkatesh KK; Farhad M; Fenton T; Moodley D; Naik S; Nakabiito C; Fairlie L; Fowler MG; Stringer JSA; Chi BH
    AIDS; 2019 Dec; 33(15):2403-2413. PubMed ID: 31764105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination antiretroviral use and preterm birth.
    Watts DH; Williams PL; Kacanek D; Griner R; Rich K; Hazra R; Mofenson LM; Mendez HA;
    J Infect Dis; 2013 Feb; 207(4):612-21. PubMed ID: 23204173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.